Fuentes GAG, Martínez SCA, Cortés HT, Rendón MAA

Language: Spanish
References: 16
Page: 104-109
PDF size: 164.17 Kb.

ABSTRACT

Laryngoscopy is one of the most painful procedures during balanced general anesthesia, which can cause hemodynamic changes. Opioids are the drugs of choice for analgesics during this process. However, some alternatives offer adequate analgesic control and hemodynamic stability during laryngoscopy, with fewer adverse effects. Our objective was to compare the hemodynamic changes during laryngoscopy between general anesthesia with opioids and opioid-free anesthesia in a Mexican population. We evaluated the information of patients who underwent laparoscopic cholecystectomy under general anesthesia in 2018 at the Nuevo Sanatorio Durango hospital. The Mann-Whitney U test for related samples was used to compare hemodynamic changes during laryngoscopy in 20 patients who received general anesthesia with fentanyl and propofol and 20 patients who received opioid-free anesthesia with dexmedetomidine, lidocaine, and propofol infusion. Changes in hemodynamic parameters during laryngoscopy did not show significant differences between the two comparison groups. Both anesthetic techniques offer similar hemodynamic stability in the Mexican population. The data obtained may generate interest for future studies and allow this technique to be increasingly adopted.

REFERENCES

1. White PF. Intravenous (non-opioid) anesthesia. Seminars in Anesthesia, Perioperative Medicine and Pain. 2005; 24 (2): 101-107.

2. Vargas-Hernández JJ. Anestesia libre de opioides. Rev Mex Anest. 2014; 37 (Suppl: 1): 24-27.

3. Bakan M, Umutoglu T, Topuz U, Uysal H, Bayram M, Kadioglu H et al. Anestesia venosa total libre de opiáceos, con infusiones de propofol, dexmedetomidina y lidocaína para la colecistectomía laparoscópica: estudio prospectivo, aleatorizado y doble ciego. Rev Bras Anestesiol. 2015; 65 (3): 191-199.

4. Cakirgoz MY, Tasdogen A, Olguner C, Korkmaz H, Ogün E, Kücükebe B et al. Efecto de diferentes dosis de esmolol sobre la respuesta hemodinámica, BIS y respuesta de movimiento durante la intubación orotraqueal: estudio prospectivo, aleatorizado y doble ciego. Rev Bras Anestesiol. 2014; 64 (6): 425-432.

5. Villarejo-Díaz M, Ramón Murillo-Zaragoza J, Alvarado-Hernández H. Farmacología de los agonistas y antagonistas de los receptores opioides. Educ Invest Clin. 2000; 1 (2): 106-1037.

6. Gil Martín A, Moreno García M, Sánchez-Rubio Ferrández J, Molina García T. Hiperalgesia asociada al tratamiento con opioides. Rev Soc Esp Dolor. 2014; 21 (5): 259-269.

7. Medlock RM, Pandit JJ. Intravenous anaesthetic agents. Anaesth Intensive Care. 2016; 17 (3): 155-162.

8. Vázquez Moyano M, Uña Orejón R. Tratamiento anestésico del paciente con adicción a drogas. Rev Esp Anestesiol Reanim. 2011; 58 (2): 97-109.

9. De Kock M. L'anesthésie sans opiacés: anecdote ou nécessité? Vol. 27. Douleur et Analgesie. France: Springer-Verlag; 2014. pp. 145-148.

10. Samuels D, Abou-Samra A, Dalvi P, Mangar D, Camporesi EM. Opioid-free anesthesia results in reduced post-operative opioid consumption. J Clin Anesth Pain Med. 2017; 1: 5-7.

11. Ayala S, Castromán P. Efecto de la lidocaína intravenosa sobre el control del dolor y el consumo de opiáceos en el postoperatorio. Anest Analg Reanim. 2012; 25 (1): 1-6.

12. Rao SH, Sudhakar B, Subramanyam PK. Haemodynamic and anaesthetic advantages of dexmedetomidine. South. Afr J Anaesth Analg. 2012; 18 (6): 326-331.

13. Albrecht E, Kirkham KR, Liu SS, Brull R. Peri-operative intravenous administration of magnesium sulphate and postoperative pain: a meta-analysis. Anaesthesia. 2013; 68 (1): 79-90.

14. Mulier J. Anestesia libre de opioides: ¿un cambio de paradigma? Rev Esp Anestesiol Reanim. 2017; 64 (8): 427-430.

15. Afonso J, Reis F. Dexmedetomidine: current role in anesthesia and intensive care. Rev Bras Anestesiol. 2012; 62 (1): 118-133.

16. Rodriguez K, Anderson R, Keriazes G, Meyers B. A retrospective review of high versus standard dose dexmedetomidine for sedation in critically ill patients. J Intensive Crit Care. 2016; 2 (2): 1-5.